Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract. - sprookjes - yvandenbroek - TriplyDB

Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract.

Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract.

http://www.wikidata.org/entity/Q37681783

about

Gonadotropin and tumorigenesis: Direct and indirect effects on inflammatory and immunosuppressive mediators and invasion.Human Chorionic Gonadotropin and Breast Cancer CGB5 expression is independently associated with poor overall survival and recurrence-free survival in patients with advanced gastric cancer.

P2860

Q38772804-2BF10B38-6796-460B-964B-3243EFA2663E Q41183501-B55978ED-8348-4828-B638-373A1788B332 Q55255417-354FBA94-8E91-4ED8-BA3D-0A720250D2FD

P2860

Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract.

http://www.wikidata.org/entity/Q37681783

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum total hCGβ level is an i ...... inoma of the urothelial tract.

@en

Serum total hCGβ level is an i ...... inoma of the urothelial tract.

@nl

type

label

Serum total hCGβ level is an i ...... inoma of the urothelial tract.

@en

Serum total hCGβ level is an i ...... inoma of the urothelial tract.

@nl

prefLabel

Serum total hCGβ level is an i ...... inoma of the urothelial tract.

@en

Serum total hCGβ level is an i ...... inoma of the urothelial tract.

@nl

P1433

Q37681783-0EDB8C2F-BD20-43B7-A051-34488A921B7F

P1476

Q37681783-8F9D3455-289B-4E50-88C9-C3C74A85CEFF

P2093

Q37681783-4922BBC9-D5F0-4FC9-BF90-AC73B2A484E8

Q37681783-49D5FE06-E446-4BD8-BAE3-028036FFA83D

Q37681783-833B130E-68C3-4F4F-895D-E43671EE74F7

Q37681783-A687B649-837F-49E9-A0C4-56B82A5FDFBD

Q37681783-BAE020C5-273D-4CE2-AB56-58EA2060C003

Q37681783-D5537723-D3FF-4ED3-BE03-E5336B5B0018

Q37681783-F5861D9B-3C30-4784-82BD-92F98181C7BE

P2860

Q37681783-09792B95-2C59-473F-8B13-D17DB86C11AF

Q37681783-2CD99068-DF89-46A4-90AA-A8FA72ABC6EF

Q37681783-30C18B72-D3B8-4985-9E5E-84516294EEDE

Q37681783-354FB53F-18DA-4AC2-8777-66BC3871349F

Q37681783-3764CC59-820B-4389-B969-45FE0422205E

Q37681783-3E2CA843-7A5C-4C0F-85C4-BE604C9AFA89

Q37681783-403E1A35-DEE5-4257-8E13-388FBE9CC2D7

Q37681783-49C85A73-1FC2-46A0-8016-ED7FCD0176D8

Q37681783-6909193A-B2EC-4F3C-B855-269850B62405

Q37681783-726DBDBA-3FB9-435A-AAF0-FAA37B742CAF

P2888

Q37681783-0CD3FD39-3475-4668-9D75-FC6D2260B1DC

P304

Q37681783-73727D14-27FF-47AA-9E75-844AC17B715D

P31

Q37681783-92ED301F-0DE9-430E-87A6-6E3A55B9D893

P356

Q37681783-C9791156-D36A-4D18-9B45-7E2B4FE7D38F

P407

Q37681783-BC59F0B3-6E70-46B2-90CE-FBBBF9441A79

P433

Q37681783-FE808C92-0F58-4B3A-B329-286CDCA2F987

P478

Q37681783-FCDCFAA1-0AD4-4ABE-90FD-6DCF17C87159

P50

Q37681783-91CACD9D-714B-4295-BE99-6743157409C8

Q37681783-C5F24658-A5D5-4945-9B7B-C9256785B33B

P577

Q37681783-4721780D-B60D-4080-AE14-FF886C7884FE

P5875

Q37681783-EEF3819E-9C35-4F9A-90BD-8E6447166410

P698

Q37681783-CE570C32-A293-43FF-9D6F-82B04135B98B

P932

Q37681783-749FECFC-8961-4E31-9EB0-2015027A076C

P356

P1433

British Journal of Cancer

P1476

Serum total hCGβ level is an i ...... cinoma of the urothelial tract

@en

P2093

A Sharp

http://www.w3.org/2001/XMLSchema#string

C Chau

http://www.w3.org/2001/XMLSchema#string

G Mead

http://www.w3.org/2001/XMLSchema#string

J Douglas

http://www.w3.org/2001/XMLSchema#string

J Head

http://www.w3.org/2001/XMLSchema#string

M Wheater

http://www.w3.org/2001/XMLSchema#string

T Drake

http://www.w3.org/2001/XMLSchema#string

P2860

Biological functions of hCG and hCG-related molecules

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling.

Generation of a concise gene panel for outcome prediction in urinary bladder cancer.

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.

P2888

P304

1759-1766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2014.89

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260370823

http://www.w3.org/2001/XMLSchema#string

P698

24556622

http://www.w3.org/2001/XMLSchema#string

P932

3974095

http://www.w3.org/2001/XMLSchema#string